Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
ACS Chemical Biology|December 31, 2014
Solution structure, aggregation behavior, and flexibility of human relaxin-2Linda M Haugaard-Kedström, Mohammed Akhter Hossain, Norelle L Daly, et al.
ACS Medicinal Chemistry Letters|October 15, 2025
Structure-Guided Temporin L Analogs Development to Inhibit the Main Protease of SARS-CoV‑2James Stewart, Ruoqing Jia, Md Ackas Ali, et al.
Journal of Biomedical Science|December 11, 2025
Immune cell uptake of glycinated nanoparticles conjugated to anti-fibrotic peptides enables their prolonged activity and oral administrationDeidree V N Somanader-Livera, Chen Wei, Chao Wang, et al.
Biochemical Pharmacology|April 28, 2024
Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4Hongkang Wu, Thomas N G Handley, Bradley L Hoare, et al.
Journal of Medicinal Chemistry|November 21, 2024
Engineering of Novel Analogues That Are More Receptor-Selective and Potent than the Native Hormone, Insulin-like Peptide 5 (INSL5)Hongkang Wu, Herodion A Hartono, Thomas N G Handley, et al.
Frontiers in Chemistry|May 3, 2014
Synthesis of fluorescent analogs of relaxin family peptides and their preliminary in vitro and in vivo characterizationLinda J Chan, Craig M Smith, Berenice E Chua, et al.
Biochemical Pharmacology|May 6, 2024
Modulation of contextual fear acquisition and extinction by acute and chronic relaxin-3 receptor (RXFP3) activation in the rat retrosplenial cortexMónica Navarro-Sánchez, Isis Gil-Miravet, Daniel Montero-Caballero, et al.
Journal of Proteome Research|May 24, 2012
Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 miceDanjun Ma, Yan Li, Bryan Hackfort, et al.
Journal of Medicinal Chemistry|November 19, 2021
Engineering of a Biologically Active Insulin DimerMengjie Liu, Barbara F White, Praveen Praveen, et al.
Pageof 15